1. Home
  2. HCAI vs XAIR Comparison

HCAI vs XAIR Comparison

Compare HCAI & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HCAI

Huachen AI Parking Management Technology Holding Co. Ltd. Ordinary Shares

HOLD

Current Price

$0.17

Market Cap

11.7M

ML Signal

HOLD

Logo Beyond Air Inc.

XAIR

Beyond Air Inc.

HOLD

Current Price

$0.80

Market Cap

10.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCAI
XAIR
Founded
2004
2011
Country
China
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.7M
10.1M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
HCAI
XAIR
Price
$0.17
$0.80
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
599.5K
215.1K
Earning Date
01-01-0001
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
62.09
EPS
N/A
N/A
Revenue
N/A
$3,705,000.00
Revenue This Year
N/A
$122.00
Revenue Next Year
N/A
$58.15
P/E Ratio
$63.07
N/A
Revenue Growth
N/A
219.67
52 Week Low
$0.17
$0.15
52 Week High
$10.97
$3.78

Technical Indicators

Market Signals
Indicator
HCAI
XAIR
Relative Strength Index (RSI) 25.01 36.34
Support Level N/A $0.67
Resistance Level $0.24 $1.25
Average True Range (ATR) 0.02 0.07
MACD -0.00 -0.00
Stochastic Oscillator 3.43 21.07

Price Performance

Historical Comparison
HCAI
XAIR

About HCAI Huachen AI Parking Management Technology Holding Co. Ltd. Ordinary Shares

Huachen AI Parking Management Technology Holding Co Ltd is a comprehensive smart parking solutions and equipment structural parts provider. The company manufactures and offer various cubic parking garage products by employing various working principles, such as lifting and shifting, convenient lifting, vertical circulation, vertical lifting, plane moving, alley stacking, multi-layer cycle, horizontal cycle, and car lift.

About XAIR Beyond Air Inc.

Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.

Share on Social Networks: